Login / Signup

Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?

Shannon A GunawardanaRobert H Shaw
Published in: BMC infectious diseases (2018)
This review concludes that our current knowledge of cross-reactive antibodies to E protein is inadequate to anticipate the outcome of deploying an E protein based vaccine to regions co-infected by DENV and ZIKV.
Keyphrases
  • zika virus
  • dengue virus
  • aedes aegypti
  • binding protein
  • protein protein
  • amino acid
  • transcription factor
  • small molecule